MedicarePartD.guide

A non-government resource built from CMS public data

Erzofri on SilverScript Choice (S5601-056)

paliperidone palmitate

Covered.

Tier 4 (non-preferred drug). Quantity limit of 0.25 per 28 days.

$248.67
Patient pays / month, after deductible
$660.72
Patient pays / month, before the $615.00 deductible
$746.00
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

ERZOFRI EXTENDED-RELEASE 39 mg/.25mL Injection at a preferred retail pharmacy, from the plan's negotiated price of $753.54 for a month. Other covered strengths are listed below.

All 6 covered strengths and forms
FormTierPatient pays / monthLimits
ERZOFRI EXTENDED-RELEASE 117 mg/.75mL Injection5$558.220.75 per 28 days
ERZOFRI EXTENDED-RELEASE 156 mg/mL Injection5$697.791 per 28 days
ERZOFRI EXTENDED-RELEASE 234 mg/1.5mL Injection5$1,395.551.5 per 28 days
ERZOFRI EXTENDED-RELEASE 351 mg/2.25mL Injection5$258.184.5 per 365 days
ERZOFRI EXTENDED-RELEASE 39 mg/.25mL Injection4$248.670.25 per 28 days
ERZOFRI EXTENDED-RELEASE 78 mg/.5mL Injection5$376.790.5 per 28 days

Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5601-056